Article History
Accepted: 5 August 2023
First Online: 26 August 2023
Compliance with Ethical Standards
:
: GSM and TTC have no relevant conflicts of interest to disclose. MJW is a consultant to Amarin, Regeneron, and The Kinetix Group, reports advisory board fees from Novartis and speaker fees from Regeneron, and has received grant support from Amgen (investigator-initiated study) and the National Institutes of Health, grant KL2TR001444. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
: This article does not contain any studies with human or animal subjects performed by any of the authors.